CASI Pharmaceuticals, Inc. is a U.S. NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products. CASI has built a portfolio that includes approved and investigational assets. We have offices in Rockville, Maryland, and a wholly-owned subsidiary in Beijing, China, through which our China operations are conducted.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Review
By reading these reviews and ratings, you agree to Tech in Asia’s terms of use.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.